Pharmacy
Some of the telehealth provisions extended on a temporary basis will be made permanent, CMS Administrator Seema Verma says.
Government and Phlow Corp. are developing a prioritized list of active pharmaceutical ingredients and medicines critically needed by health systems.
While it hasn't yet been tested in humans, its ability to target multiple coronaviruses shows early promise.
The public and private partnership includes the Department of Defense to enable faster distribution.
Hydroxychloroquine can reduce inflammation, pain and swelling, but mild to moderate COVID patients showed more adverse events when treated with it.
The treatment may reduce the risk to healthcare workers because it reduces the duration and quantity of viral shedding.
Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.
One promising candidate is remdesivir, a drug originally developed for Ebola, which the FDA has approved for emergency use during the pandemic.
Consumer-centric digital services could become the new norm, according to CEO and President Larry Merlo.
The results aim to act as a "playbook" of sorts for leaders and administrators who are looking for better ways to keep their group properly trained.